Lv2
120 积分 2025-09-28 加入
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
18天前
已完结
CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
1个月前
已完结
Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system
1个月前
已完结
Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma
2个月前
已完结
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
3个月前
已完结
B细胞易位基因1对耐利妥昔单抗的SU-DHL-2细胞的抑制作用
3个月前
已完结
B细胞易位基因1对B细胞淋巴瘤增殖的影响
3个月前
已完结
B细胞易位基因1对B细胞淋巴瘤增殖的影响
3个月前
已关闭
皖公网安备34019202002308
